# MagnetisMM-32: A Study to Learn About the Study Medicine Called Elranatamab in People With Multiple Myeloma (MM) That Has Come Back After Taking Other Treatments (Including Prior Treatment With an Anti-CD38 Antibody and Lenalidomide)

> clinical trial · VERIFIED · 2026-08-24

Status: RECRUITING · Sponsor: Pfizer · Condition: Multiple Myeloma

- Company: Pfizer
- Sector: oncology
- Primary source: https://clinicaltrials.gov/study/NCT06152575

---
Source: MedFuel Intel news monitor. Verification tier: VERIFIED. Informational only, not investment advice. Corrections: media@medfuelinc.com.